Why Biora Therapeutics (BIOR) Stock Is Down 45%
Why Biora Therapeutics (BIOR) Stock Is Down 45%
Biora Therapeutics Inc (NASDAQ:BIOR) shares are trading lower by 45% to 74 cents during Tuesday's session after the company announced that it will be delisted from Nasdaq following a decision by the Nasdaq Hearings Panel due to non-compliance with the market value requirements under Nasdaq Listing Rule 5550(b).
Biora Therapeutics Inc（纳斯达克股票代码：BIOR）股价在周二的交易中下跌了45％，至74美分，此前该公司宣布，在纳斯达克听证会小组因未遵守纳斯达克上市规则5550（b）的市值要求而做出决定后，该公司将从纳斯达克退市。
Biora Therapeutics says trading of the company's securities on Nasdaq will cease at the opening of business on December 11, with Nasdaq filing a Form 25 to formalize the delisting after all appeal periods expire.
Biora Therapeutics表示，该公司在纳斯达克的证券交易将在12月11日开业时停止，纳斯达克将在所有上诉期到期后提交25号表格，以正式退市。
Biora anticipates its shares will transition to trading on the OTC Pink Current Information tier under the ticker symbol "BIOR" immediately following the Nasdaq suspension.
Biora预计，在纳斯达克停牌后，其股票将立即过渡到场外粉红当前信息层的交易，股票代码为 “BIOR”。
Read Also: Why Interactive Strength Stock Is Trading Higher
另请阅读：为什么互动强度股票的交易价格走高
According to data from Benzinga Pro, BIOR has a 52-week high of $19.90 and a 52-week low of $0.70.
根据Benzinga Pro的数据，BIOR的52周高点为19.90美元，52周低点为0.70美元。
